Table Info

Table 1.

Characteristics of the study participants

Profile		Number (n = 103)	(%)
Age (years)	≤ 40	90	87.38
Age (years)	> 40	13	12.62
Gender	Male	42	40.78
Gender	Female	61	59.22
Body mass index	Underweight	2	1.94
	Normal	26	25.24
	Overweight	28	27.18
	Obesity class 1	33	32.04
	Obesity class 2	14	13.59
Occupation	Doctor	34	33.01
	Nurse	58	56.31
	Other	11	10.68
Work unit	Intensive care unit	20	19.42
	Emergency room	25	24.27
	Ward	19	18.45
	Policlinic	19	18.45
	Operation room	20	19.42
COVID-19 history	Infected	73	70.87
COVID-19 history	Non-infected	30	29.13
Vaccination frequency (times)	2	5	4.85
	3	79	76.70
	4	19	18.45
Duration (months)	6–12	6	5.83
	13–18	16	15.53
	18–24	33	32.04
	25–31	48	46.60
Vaccine combination	2 Inactive - 2 mRNA	14	13.59
	2 Inactive - mRNA	78	75.73
	Others	11	10.68
Vaccine status	Full-Infected	10	9.71
	Full-Non Infected	9	8.74
	Not Full-Infected	63	61.17
	Not Full-Non Infected	21	20.39
IgG antibody	Seropositive	102	99.03
IgG antibody	Seronegative	1	0.97

IgG: Immunoglobulin G; mRNA: messenger RNA; Full-Infected: vaccinated 4 times and confirmed COVID-19; Full-Non Infected: vaccinated 4 times and not confirmed COVID-19; Not Full-Infected: < 4 vaccinations and confirmed COVID-19; Not Full-Non Infected: < 4 vaccinations and not confirmed COVID-19

Supplementary materials

The supplementary materials for this article are available at: https://www.explorationpub.com/uploads/Article/file/1003166_sup_1.pdf.

Declarations

Acknowledgments

The authors are grateful to all participants who have consented to include the data for the study as well as Isnaeni, a virology laboratory analyst, for the assistance in processing samples. The authors are also grateful to the First Affiliated Hospital of Dr. Wahidin Sudirohusodo as well as Prihantono, Nurpudji Astuti Taslim, Firdaus Kasim, and Andriany Qanitha for tutoring and assisting in compiling the manuscript.

Author contributions

IN, EA, NAT, ID, BN, SN: Conceptualization, Investigation, Methodology, Data curation, Validation. JH, AA: Statistical analysis, Supervision. IN, RR: Writing—original draft, Writing—review & editing. MAGM: Writing—review & editing. All authors read and approved the submitted version.

Conflicts of interest

The authors declare that there are no conflicts of interest.

Ethical approval

All participants gave written informed consent following the Declaration of Helsinki. The Ethical Committee of the Medical Faculty of Hasanuddin University approved the procedure applied in this study (750/UN4.6.4.5.31/PP36/2023).

Consent to participate

Informed consent to participate in the study was obtained from all participants.

Consent to publication

The consent for publication has been obtained from all participants.

Availability of data and materials

Data are available in the supplementary materials. Supporting raw data for this study are available from the corresponding author upon reasonable inquiry.

Funding

Not applicable.

Copyright

References

Bilal M, Khan MI, Nazir MS, Ahmed I, Iqbal HMN. Coronaviruses and COVID-19 – Complications and Lessons Learned for the Future. J Pure Appl Microbiol. 2020;14:725–31. [DOI]

Jhonet A, Rolin S, Triwahyuni T, Putri DF. Relationship of Depression Levels with COVID-19 Symptoms Post Self-Isolation. JIKSH. 2022;11:192–200. Indonesian.

WHO COVID-19 dashboard [Internet]. WHO; c2024 [cited 2023 June 9]. Available from: https://data.who.int/dashboards/covid19/vaccines?n=c

Peta Sebaran [Internet]. Satuan Tugas Penanganan COVID-19; c2021 [cited 2023 June 9]. Available from: https://covid19.go.id/peta-sebaran

Vaksinasi COVID-19 Nasional [Internet]. KEMENTERIAN KESEHATAN REPUBLIK INDONESIA; c2022 [cited 2023 June 9]. Available from: https://vaksin.kemkes.go.id/#/vaccines

Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19) [Internet]. Direktorat Utama Pembinaan dan Pengembangan Hukum Pemeriksaan Keuangan Negara Badan Pemeriksa Keuangan; [cited 2023 June 9]. Available from: https://peraturan.bpk.go.id/Details/169665/permenkes-no-10-tahun-2021

Gu M, Taylor B, Pollack HA, Schneider JA, Zaller N. A pilot study on COVID-19 vaccine hesitancy among healthcare workers in the US. PLoS One. 2022;17:e0269320. [DOI] [PubMed] [PMC]

Ackah M, Ameyaw L, Salifu MG, Asubonteng DPA, Yeboah CO, Annor EN, et al. COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis. PLoS One. 2022;17:e0268711. [DOI] [PubMed] [PMC]

Giubilini A, Savulescu J, Pugh J, Wilkinson D. Vaccine mandates for healthcare workers beyond COVID-19. J Med Ethics. 2023;49:211–20. [DOI] [PubMed] [PMC]

10.

Pan S, Manabe N, Yamaguchi Y. 3D Structures of IgA, IgM, and Components. Int J Mol Sci. 2021;22:12776. [DOI] [PubMed] [PMC]

11.

Diem S, Fässler M, Bomze D, Ali OH, Berner F, Niederer R, et al. Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. J Immunother. 2019;42:89–93. [DOI] [PubMed]

12.

Vernet R, Charrier E, Grogg J, Mach N. A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein. Vaccines (Basel). 2021;9:770. [DOI] [PubMed] [PMC]

13.

Miesse PK, Collier BB, Grant RP. Monitoring of SARS-CoV-2 antibodies using dried blood spot for at-home collection. Sci Rep. 2022;12:5812. [DOI] [PubMed] [PMC]

14.

Mazhari R, Ruybal-Pesántez S, Angrisano F, Kiernan-Walker N, Hyslop S, Longley RJ, et al. SARS-CoV-2 Multi-Antigen Serology Assay. Methods Protoc. 2021;4:72. [DOI] [PubMed] [PMC]

15.

He Z, Ren L, Yang J, Guo L, Feng L, Ma C, et al. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. Lancet. 2021;397:1075–84. [DOI] [PubMed] [PMC]

16.

Guzmán-Martínez O, Guardado K, Varela-Cardoso M, Trujillo-Rivera A, Marín-Hernández A, Ortiz-León MC, et al. Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients. Infection. 2022;50:447–56. [DOI] [PubMed] [PMC]

17.

Megasari NLA, Yamani LN, Juniastuti J, Lusida MI, Mori Y. Seroprevalence of SARS-CoV-2 anti-spike IgG antibody among COVID-19 vaccinated individuals residing in Surabaya, East Java, Indonesia. PeerJ. 2023;11:e16142. [DOI] [PubMed] [PMC]

18.

Houmich TB, Tali A, Debbagh F, Hanchi AL, Soraa N. Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco). Int J Immunopathol Pharmacol. 2022;36:3946320221133697. [DOI] [PubMed] [PMC]

19.

Ariawan I, Jusril H, Farid MN, Riono P, Wahyuningsih W, Widyastuti W, et al. SARS-CoV-2 Antibody Seroprevalence in Jakarta, Indonesia. Kesmas. 2022;17:169–74. [DOI]

20.

Hossain A, Nasrullah SM, Tasnim Z, Hasan MK, Hasan MM. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis. EClinicalMedicine. 2021;33:100770. [DOI] [PubMed] [PMC]

21.

Iyer AS, Jones FK, Nodoushani A, Kelly M, Becker M, Slater D, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020;5:eabe0367. [DOI] [PubMed] [PMC]

22.

Lumley SF, O’Donnell D, Stoesser NE, Matthews PC, Howarth A, Hatch SB, et al.; Oxford University Hospitals Staff Testing Group. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. N Engl J Med. 2021;384:533–40. [DOI] [PubMed] [PMC]

23.

Oved K, Olmer L, Shemer-Avni Y, Wolf T, Supino-Rosin L, Prajgrod G, et al. Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation. EClinicalMedicine. 2020;29:100651. [DOI] [PubMed] [PMC]

24.

Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184:861–80. [DOI] [PubMed] [PMC]

25.

Jain S, Batra H, Yadav P, Chand S. COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response. Vaccines (Basel). 2020;8:649. [DOI] [PubMed] [PMC]

26.

Sugiyama A, Kurisu A, Nagashima S, Hando K, Saipova K, Akhmedova S, et al. Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers. Sci Rep. 2022;12:16294. [DOI] [PubMed] [PMC]

27.

Feng S, Phillips DJ, White T, Sayal H, Aley PK, Bibi S, et al.; Oxford COVID Vaccine Trial Group. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021;27:2032–40. [DOI] [PubMed] [PMC]

28.

Bauer G. High avidity of vaccine-induced immunoglobulin G against SARS-CoV-2: potential relevance for protective humoral immunity. Explor Immunol. 2022;2:133–56. [DOI]

29.

Kodde C, Tafelski S, Balamitsa E, Nachtigall I, Bonsignore M. Factors Influencing Antibody Response to SARS-CoV-2 Vaccination. Vaccines (Basel). 2023;11:451. [DOI] [PubMed] [PMC]

30.

Vassilaki N, Gargalionis AN, Bletsa A, Papamichalopoulos N, Kontou E, Gkika M, et al. Impact of Age and Sex on Antibody Response Following the Second Dose of COVID-19 BNT162b2 mRNA Vaccine in Greek Healthcare Workers. Microorganisms. 2021;9:1725. [DOI] [PubMed] [PMC]

31.

Damerau L, Mühlenbruch G, Evenschor-Ascheid A, Fussen C, Nienhaus A, Terschüren C, et al. Coronavirus Vaccination: Spike Antibody Levels in Health Workers after Six Months-A Cross-Sectional Study. Int J Environ Res Public Health. 2022;19:11422. [DOI] [PubMed] [PMC]

32.

Kutsuna S, Asai Y, Matsunaga A, Kinoshita N, Terada M, Miyazato Y, et al. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J Infect Chemother. 2021;27:808–13. [DOI] [PubMed] [PMC]

33.

Nurisyah S, Iyori M, Hasyim AA, Sakamoto A, Hashimoto H, Yamagata K, et al. Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort. Antibodies (Basel). 2023;12:60. [DOI] [PubMed] [PMC]

34.

Hall V, Foulkes S, Insalata F, Kirwan P, Saei A, Atti A, et al.; SIREN Study Group. Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection. N Engl J Med. 2022;386:1207–20. [DOI] [PubMed] [PMC]

35.

Rolando LM, Villafañe JH, García SC, Argüello AS, Rosa MV, Romero EAS. Multicomponent Exercise Program to Improve the Immediate Sequelae of COVID-19: A Prospective Study with a Brief Report of 2-Year Follow-Up. Int J Environ Res Public Health. 2022;19:12396. [DOI] [PubMed] [PMC]

36.

Osses-Anguita ÁE, Sánchez-Sánchez T, Soto-Goñi XA, García-González M, Alén Fariñas F, Cid-Verdejo R, et al. Awake and Sleep Bruxism Prevalence and Their Associated Psychological Factors in First-Year University Students: A Pre-Mid-Post COVID-19 Pandemic Comparison. Int J Environ Res Public Health. 2023;20:2452. [DOI] [PubMed] [PMC]